Back to search

University of Patras

Σχεδιασμός, έκφραση και δομικές μελέτες τμημάτων του ανθρώπινου νευρωνικού νικοτινικού υποδοχέα ακετυλοχολίνης

Abstract

dc:description

Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels of the Cys-loop superfamily. Cys-loop receptors mediate and regulate fast neurotransmission. They are ion channels of five homologous subunits, each comprising an N-terminal extracellular domain (ECD), a transmembrane domain and an intracellular domain (ICD). The neurotransmitter (orthosteric) binding site is extracellularly located and formed at the interface of adjacent subunits by two components: the principal and the complementary sides, which, in nAChRs, are conferred by an α subunit and a neighboring (α or non α) subunit, respectively. Until recently, our understanding of neuronal nAChRs structure was largely limited to insights from structures of homologous proteins. Structures of nAChRs would be instrumental to understand their physiology and to aid development of selective drugs to treat conditions that implicate nAChR dysfunction and include neurological and psychiatric disorders, substance addiction, inflammation and pain. The α9 subunit of neuronal nAChRs either forms homopentamers or, in association with α10, heteropentamers. Recently, α9-containing receptors (α9*nAChRs) have emerged as important players in pro-inflammatory pathways and in the treatment of chronic pain. In literature, heterologous expression of α9*nAChRs has been reported as challenging, while there are no reports of successful expression of α9*nAChRs, amenable to structural studies. Difficulties in obtaining sufficient quantities of receptor suitable for structural studies pose a major barrier towards that goal. Therefore, this study includes expression and biochemical characterization of selected domains of α9*nAChRs. In order to produce such domains, ultimately aiming at structural studies, two strategies were followed: (i) expression of water-soluble forms of either α9-ECD or α10-ECD and (ii) design, construction and expression of truncated forms of α9 and α10 subunits, engineered at their ICD, so as to obtain membrane-embedded forms of α9 or α9α10 nAChRs. The α9-ECD was expressed in yeast Pichia pastoris and, through chromatographic analysis, a homogeneous monomeric population was isolated for the glycoprotein or, following enzymatic treatment, its deglycosylated form, as well. The monomeric α9-ECD does not include a fully formed orthosteric binding site. Nevertheless, its pharmacological characterization showed that it retains moderate to high binding affinity for several cholinergic ligands, often comparable to those observed for native α9*nAChRs, especially for the antagonists d-tubocurarine, α-bungarotoxin (α-Bgtx) and methyllycaconitine (MLA). These results highlight the major contribution of the principal side of the orthosteric binding site to ligand binding. Crystallisation trials of the deglycosylated monomeric α9-ECD, in the absence of ligands or in the presence of MLA or α-Bgtx, resulted to the formation of X-ray diffracting crystals, that finally led to the determination of the crystal structures of the α9-ECD, in its ligand-free state and in its complexes with MLA or α-Bgtx, at resolutions of 1.8 Å, 1.7 Å and 2.7 Å, respectively. These structures were the first to be reported for a neuronal nAChR ECD. The crystal structure of the α9-ECD superimposed well with the corresponding domains of structures of homologous pentameric proteins, suggesting that the isolated ECD adopts native-like folding, despite the absence of the membrane domain or adjacent subunits. In the structures of its complexes, the interaction motifs of both antagonists and their orientation in the principal side of the orthosteric site were similar to those observed in their complexes with homologous proteins in pentameric assemblies, which display fully form binding sites, thus further highlighting the major contribution of the principal side of α9-ECD to their binding. Expression of α10-ECD (with a single mutation to enhance its solubility), in yeast Pichia pastoris, led to the formation of aggregates and only a small proportion of monomers, rendering it unattractive for further analysis. Regarding engineered receptors, expression of several α9 constructs in bacteria, yeast or Sf9 insect cells, as well as co-expression of α9 and α10 in Sf9, failed to lead to the isolation of a stable and homogeneous pentameric population, as required for structural studies. Subsequently, design and expression in Sf9, of another construct of α9 (α9Μ), with moderate truncation of the ICD, led to the successful isolation of a stable pentameric population that displays α-Bgtx binding, suggesting that detergent solubilized receptors partially retain their functionality. The methodology reported here for isolation of near intact homopentamers of α9Μ, which seem to be promising candidates for structural studies, should pave the way for future high-resolution studies of the α9 nAChR either by crystallographic or Electron cryo-Microscopy analysis.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zarkadas, Eleftherios
  • Ζαρκάδας, Ελευθέριος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43501

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zarkadas, Eleftherios; Ζαρκάδας, Ελευθέριος. Σχεδιασμός, έκφραση και δομικές μελέτες τμημάτων του ανθρώπινου νευρωνικού νικοτινικού υποδοχέα ακετυλοχολίνης. University of Patras, 2018. http://hdl.handle.net/10442/hedi/43501